Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Jasper Therapeutics Inc shares valued at $19,899 were sold by Mahal Jeetinder Singh on Dec 12 ’24. At $22.11 per share, Mahal Jeetinder Singh sold 900 shares. The insider’s holdings dropped to 25,009 shares worth approximately $0.15 million following the completion of this transaction.
Also, Jeetinder Singh Mahal purchased 900 shares, netting a total of over 20,223 in proceeds.
Before that, Mahal Jeetinder Singh had sold 900 shares from its account. In a trade valued at $19,104, the Chief Operating Officer traded Jasper Therapeutics Inc shares for $21.23 each. Upon closing the transaction, the insider’s holdings decreased to 900 shares, worth approximately $0.15 million.
As published in their initiating research note from BMO Capital Markets on December 06, 2024, Jasper Therapeutics Inc [JSPR] has been an Outperform and the price target has been revised to $63. Analysts at JMP Securities started covering the stock with ‘”a Mkt outperform”‘ outlook in a report released in early September. As of July 08, 2024, BTIG Research has initiated its “Buy” rating for JSPR. Earlier on June 27, 2024, Stifel initiated its rating. Their recommendation was “a Buy” for JSPR stock.
Analyzing JSPR Stock Performance
During the last five days, there has been a surge of approximately 0.86%. Over the course of the year, Jasper Therapeutics Inc shares have dropped approximately -72.54%. Shares of the company reached a 52-week high of $22.52 on 01/02/25 and a 52-week low of $5.25 on 01/17/25. A 50-day SMA is recorded $18.74, while a 200-day SMA reached $20.59. Nevertheless, trading volume fell to 0.48 million shares from 0.55 million shares the previous day.
Support And Resistance Levels for Jasper Therapeutics Inc (JSPR)
According to the 24-hour chart, there is a support level at 5.72, which, if violated, would cause prices to drop to 5.58. In the upper region, resistance lies at 6.13. The next price resistance is at 6.40. RSI (Relative Strength Index) is 21.09 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -4.12, which suggests the price will decrease in the coming days. Percent R is at 96.41%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
Which companies own the most shares of Jasper Therapeutics Inc (JSPR)?
On May 06, 2024, H.C. Wainwright assigned a price target of “a Buy” to the stock and initiated coverage with a $65.
